A detailed history of Gibraltar Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gibraltar Capital Management, Inc. holds 112,171 shares of BMY stock, worth $5.46 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares
112,171
Previous 110,072 1.91%
Holding current value
$5.46 Million
Previous $5.97 Million 21.96%
% of portfolio
2.16%
Previous 2.86%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$40.25 - $52.99 $84,484 - $111,226
2,099 Added 1.91%
112,171 $4.66 Million
Q1 2024

May 06, 2024

BUY
$47.98 - $54.4 $1.57 Million - $1.78 Million
32,691 Added 42.25%
110,072 $5.97 Million
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $766,856 - $915,071
-15,818 Reduced 16.97%
77,381 $3.97 Million
Q3 2023

Oct 13, 2023

BUY
$57.89 - $64.73 $122,379 - $136,839
2,114 Added 2.32%
93,199 $5.41 Million
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $107,542 - $119,409
1,688 Added 1.89%
91,085 $5.82 Million
Q1 2023

May 05, 2023

BUY
$65.71 - $74.53 $75,895 - $86,082
1,155 Added 1.31%
89,397 $6.2 Million
Q4 2022

Jan 13, 2023

BUY
$68.48 - $81.09 $67,795 - $80,279
990 Added 1.13%
88,242 $0
Q3 2022

Oct 26, 2022

SELL
$0.13 - $76.84 $534 - $316,119
-4,114 Reduced 4.5%
87,252 $6.2 Million
Q2 2022

Jul 19, 2022

SELL
$72.62 - $79.98 $984,146 - $1.08 Million
-13,552 Reduced 12.92%
91,366 $7.04 Million
Q1 2022

Apr 11, 2022

BUY
$61.48 - $73.72 $45,433 - $54,479
739 Added 0.71%
104,918 $7.66 Million
Q4 2021

Jan 21, 2022

SELL
$53.63 - $62.52 $213,447 - $248,829
-3,980 Reduced 3.68%
104,179 $6.5 Million
Q3 2021

Oct 13, 2021

BUY
$59.17 - $69.31 $205,970 - $241,268
3,481 Added 3.33%
108,159 $6.4 Million
Q2 2021

Jul 13, 2021

BUY
$61.91 - $67.42 $385,823 - $420,161
6,232 Added 6.33%
104,678 $6.98 Million
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $837,050 - $941,434
14,106 Added 16.73%
98,446 $6.2 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $50,349 - $57,054
872 Added 1.04%
84,340 $5.23 Million
Q3 2020

Nov 05, 2020

SELL
$57.43 - $63.64 $297,717 - $329,909
-5,184 Reduced 5.85%
83,468 $5.03 Million
Q2 2020

Jul 15, 2020

SELL
$54.82 - $64.09 $54,545 - $63,769
-995 Reduced 1.11%
88,652 $5.21 Million
Q1 2020

Apr 16, 2020

SELL
$46.4 - $67.43 $94,192 - $136,882
-2,030 Reduced 2.21%
89,647 $5 Million
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $548,986 - $716,103
11,156 Added 13.85%
91,677 $5.89 Million
Q3 2019

Oct 09, 2019

BUY
$42.77 - $50.71 $220,051 - $260,902
5,145 Added 6.83%
80,521 $4.08 Million
Q2 2019

Jul 17, 2019

BUY
$44.62 - $49.34 $37,971 - $41,988
851 Added 1.14%
75,376 $3.42 Million
Q1 2019

Apr 11, 2019

BUY
$45.12 - $53.8 $3.36 Million - $4.01 Million
74,525 New
74,525 $3.56 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gibraltar Capital Management, Inc. Portfolio

Follow Gibraltar Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gibraltar Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gibraltar Capital Management, Inc. with notifications on news.